Deutsche Bank Aktiengesellschaft Boosts HealthEquity (NASDAQ:HQY) Price Target to $128.00

HealthEquity (NASDAQ:HQY) had its price objective lifted by research analysts at Deutsche Bank Aktiengesellschaft from $120.00 to $128.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 58.11% from the company’s previous close.

A number of other analysts have also recently weighed in on the stock. The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target on the stock. in a report on Friday, January 9th. BTIG Research reduced their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. JPMorgan Chase & Co. decreased their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a report on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.36.

HealthEquity Trading Down 0.2%

Shares of NASDAQ:HQY opened at $80.96 on Thursday. The company has a market capitalization of $6.84 billion, a PE ratio of 32.91, a P/E/G ratio of 1.48 and a beta of 0.26. The company has a current ratio of 3.27, a quick ratio of 4.13 and a debt-to-equity ratio of 0.45. HealthEquity has a 12-month low of $72.76 and a 12-month high of $116.65. The business’s fifty day simple moving average is $80.32 and its 200-day simple moving average is $90.08.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The firm had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity’s revenue for the quarter was up 7.3% compared to the same quarter last year. As a group, equities research analysts predict that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Xponance Inc. lifted its position in HealthEquity by 0.8% during the 3rd quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after acquiring an additional 102 shares during the period. Advisors Asset Management Inc. increased its holdings in HealthEquity by 4.7% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock worth $255,000 after buying an additional 110 shares during the period. Truist Financial Corp increased its holdings in HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after buying an additional 119 shares during the period. Fiduciary Trust Co raised its position in HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after buying an additional 120 shares during the last quarter. Finally, Larson Financial Group LLC raised its position in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after buying an additional 123 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.